[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)
Madrigal Pharmaceuticals (MDGL) is trending due to acquisition speculation and positive clinical data, with Oppenheimer raising the price target. The stock price hit a 52-week high of $XXXXXX for the hour.
About Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a biopharmaceutical company focused on therapeutics for non-alcoholic steatohepatitis (NASH).
Madrigal Pharmaceuticals, Inc. Common Stock uses the ticker $MDGL for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) trading volume is up XXXXX% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) social dominance is up XXXXXX% from the previous month.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) sentiment is up XXXXX% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) posts created is up XXXXX% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock Price hit a 52-Week high of XXXXXX for the hour
- Madrigal Pharmaceuticals, Inc. Common Stock Price hit an all time of XXXXXX for the hour
Price: $XXXXXX #
Price 24-Hour Time-Series Raw Data
The current price decline to $XXXXXX is likely due to profit-taking, despite positive sentiment and strong social engagement driven by acquisition rumors and positive news, as the stock is up XXXX% in the last XX hours.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXXX% | XXXXX% |
1-Year High: $XXXXXX on 2025-10-15
1-Year Low: $XXXXXX on 2024-10-23
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently AltRank #1,307 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +197
1 Month: XXXXX +47
6 Months: XXXXX -XXX
1 Year: XXXXX +832
1-Year High: XXXXX on 2025-09-24
1-Year Low: X on 2024-11-02
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +3
1 Month: XX +2
6 Months: XX +14
1 Year: XX -XX
1-Year High: XX on 2025-02-26
1-Year Low: XX on 2024-11-15
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +4.10%
1 Year: XXXXXXXXXX +18%
1-Year High: XXXXXXX on 2024-11-01
1-Year Low: XXXXX on 2025-10-15
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX -XX%
1 Year: XXXXXX +258%
1-Year High: XXXXX on 2025-07-17
1-Year Low: XX on 2024-10-17
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XX -XX%
6 Months: XXXXX +49%
1 Year: XXXXX +216%
1-Year High: XXX on 2025-07-17
1-Year Low: XX on 2025-09-15
The most influential creators that mention Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @RyshabTalks | X | XXX | X | XXX |
| @StockMarke18287 | X | XXX | XX | XXX |
| @Pharmdca | X | XXXXXXX | X | XXX |
| @sssc | X | XXXXX | X | XXX |
| @a_a_free | X | XXX | X | XXX |
| @mikeycolombia33 | X | XXXXX | XX | XXX |
| @WallStSai | X | XXXXX | X | XXX |
| @bioinvestor24 | X | XXXXX | X | XXX |
| @SeanValenc89161 | X | XX | X | XXX |
| @doepke_michel | XX | XXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +13%
1 Month: XX% -X%
6 Months: XX% +25%
1 Year: XX% -X%
1-Year High: XX% on 2025-09-03
1-Year Low: XX% on 2024-10-21
Most Supportive Themes
- Potential Acquisition by Big Pharma: (45%) Madrigal is seen as an attractive acquisition target by big pharma.
- Positive Clinical Data and Market Leadership: (30%) Positive clinical trial results for Rezdiffra and Madrigal's market leadership in MASH are highlighted.
- Undervalued Stock: (20%) Many investors believe MDGL is undervalued, suggesting a strong buying opportunity.
Most Critical Themes
- Price Dip and Market Manipulation: (5%) The recent price decline is being attributed to profit-taking and potential market manipulation.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.0033%
1 Month: XXXXX% +0.012%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% +0.0089%
1-Year High: XXXXX% on 2025-01-24
1-Year Low: XXXXXX% on 2025-10-03
Market Dominance: XXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-25
1-Year Low: XXXXXXX% on 2024-10-22
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.19%
1 Month: $XXXXXXXXXXXXX +$1.10%
6 Months: $XXXXXXXXXXXXX +$46%
1 Year: $XXXXXXXXXXXXX +$108%
1-Year High: $XXXXXXXXXXXXXX on 2025-09-30
1-Year Low: $XXXXXXXXXXXXX on 2024-10-23
Top assets mentioned In the posts about Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours
Dollar Tree Inc (DLTR) Pfizer, Inc. (PFE) Dollar Tree Inc (DLTR) Akropolis (AKRO) Viking Therapeutics, Inc (VKTX) Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Novo-Nordisk (NVO) R1 RCM Holdco, Inc. (RCM)
Top topics mentioned In the posts about Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours
stocks healthcare, stocks consumer defensive, dollar tree inc, $pfe, $dltr, $akro, $vktx, johnson johnson, $jnj, stocks technology, $nvo, r1 rcm holdco inc, $rcm, $mrk, $eem, $insm, $bmy, coins defi, stocks financial services, investment, $adhcon, $alab, telegram, $rytm, $smmt, $rvmd, stocks communication services, stocks bitcoin treasuries, $bbio, $dave, $spy, $qqq, $adhc0015, $hood, $incy, $abbv, $iwm, $rddt, $xbi, $etnb, $adhcfda, $adhc, $adhc0016, $krtx, coins dao, $bmrn, $pgy, $vrna, $iccm, $onc, $acad, hims hers, $hims, stocks basic materials, $knsa, alnylam pharmaceuticals inc, $alny, goldman sachs, $imgn, royal bank of canada, combo, acquisition, $crmd, applovin, $myok, $cytk, coins nft, insider, $kura, $mlys, $blue, $zyme, $crdo, $iva, $jazz, $rna, $idya, $apge, $mrus, $coo, $lab, $buse, $vbix, $ions, $rigl, drugs, stocks consumer cyclical, $ua, $uaa, under armour, $58k, electronic arts inc, $ea, zoom video communications inc, $mbin, morgan stanley, $mir, $teck, $amr, $vani
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Truist🏁 $MDGL Buy/$580 and says KOL Feedback Shows High Interest in Rezdiffra and Supports Peak Sales of $6.2B in its View. $IVA $NVO Truist said in its MDGL initiation: Key investment points - 1) First drug approved (Rezdiffra) for MASH with early launch metrics indicating high demand & potential for upside from continued strong launch; 2) Sizable opportunity in MASH (10-20M US patients) not fully reflected at current levels; 3) KOL feedback shows high interest in Rezdiffra in our view supports peak sales of $6.2B vs. $4.5B cons (2036E) in the approved F2/F3 subtype; 4) Potential for upside"
X Link @Quantumup1 2025-10-14T20:14Z 3827 followers, 2582 engagements
"$PGY $DLTR $MDGL To Analyst price target for next week-"
X Link @StockMarke18287 2025-10-14T19:09Z XXX followers, XXX engagements
"$RCM $DLTR $MDGL To Analyst price target for next week-"
X Link @StockMarke18287 2025-10-14T19:07Z XXX followers, XXX engagements
"$HOOD $DLTR $MDGL To Analyst price target for next week-"
X Link @StockMarke18287 2025-10-14T19:03Z XXX followers, XXX engagements